Novel oral fast-disintegrating drug delivery devices with predefined inner structure fabricated by Three-Dimensional Printing
Tóm tắt
Novel fast-disintegrating drug delivery devices with special inner structure characteristics were designed and fabricated using Three-Dimensional Printing.
Based on computer-aided design models, fast-disintegrating drug delivery devices containing loose powders were prepared automatically using the Three-Dimensional Printing system. The inner powder regions were prepared by depositing the binder solutions onto selected regions during the layer-printing process.
The devices showed acceptable pharmacotechnical properties and fine hardness (63.4 N/cm2) due to the synergistic action of several binding mechanisms, but unsatisfactory friability, with 3.55% total mass loss during the friability tests. Scanning electron microscope images clearly showed that the printed regions were well bound, and that the drug particle size was reduced or individual particles could no longer be distinguished. In contrast, the unprinted regions were uncompacted, with cracks and fissures among the loose mixed powder. All the drug delivery devices disintegrated and wetted rapidly in in-vitro tests. The average disintegration and wetting times were 23.4 s and 67.6 s, respectively. Dissolution tests showed that 98.5% of the drug was released within 2 min.
Three-Dimensional Printing offers strategies for the development of novel oral fast-disintegrating drug delivery devices.
Từ khóa
Tài liệu tham khảo
Fu, 2004, Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies, Crit Rev Ther Drug Carr Sys, 21, 433, 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10
Ahmed, 2007, In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin, Eur J Pharm Sci, 32, 58, 10.1016/j.ejps.2007.05.114
Goddeeris, 2008, Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781, Eur J Pharm Sci, 34, 293, 10.1016/j.ejps.2008.05.005
Schiermeier, 2002, Fast dispersible ibuprofen tablets, Eur J Pharm Sci, 15, 295, 10.1016/S0928-0987(02)00011-8
Yu, 2008, Three-dimensional printing in pharmaceutics – promises and problems, J Pharm Sci, 97, 3666, 10.1002/jps.21284
Habih, 2000, Fast-dissolve drug delivery systems, Crit Rev Ther Drug Carrier Sys, 17, 61
Sachs, 1992, Three-Dimensional Printing™: rapid tooling and prototypes directly from a CAD model, J Eng Ind, 114, 481, 10.1115/1.2900701
Wu, 1996, Solid free-form fabrication of drug delivery devices, J Control Release, 40, 77, 10.1016/0168-3659(95)00173-5
Katstra, 2000, Oral dosage forms fabricated by Three Dimensional Printing™, J Control Release, 66, 1, 10.1016/S0168-3659(99)00225-4
Yu, 2007, Tablets with material gradients fabricated by three-dimensional printing, J Pharm Sci, 96, 2446, 10.1002/jps.20864
Yu, 2007, Zero-order controlled-release tablets of helicid fabricated by three dimensional printing technology, Chin Tradit Pat Med, 29, 355
Chinese Pharmacopoeia Committee., 2005, Pharmacopoeia of the People's Republic of China
Fell, 1970, Determination of tablet strength by diametral compression test, J Pharm Sci, 59, 688, 10.1002/jps.2600590523
Rawas-Qalaji, 2006, Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics, AAPS Pharm Sci Tech, 7, 10.1208/pt070241
Abdelbary, 2005, Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration, Int J Pharm, 292, 29, 10.1016/j.ijpharm.2004.08.019
Leuner, 2000, Improving drug solubility for oral delivery using solid dispersions, Eur J Pharm Biopharm, 50, 47, 10.1016/S0939-6411(00)00076-X
Rasenack, 2002, Crystal habit and tableting behavior, Int J Pharm, 244, 45, 10.1016/S0378-5173(02)00296-X
Bühler, 1998, Kollidon®: Polyvinylpyrollidone for the Pharmaceutical Industry, 2nd
Fan, 1995, Droplet-powder impact interaction in three-dimensional printing
2000, US Pharmacopeia XXIV